Metoprolol Succinate
Brand name: Metoprolol Succinate
Rank #75 of 500 drugs by total cost
$256.3M
Total Cost
12,847,535
Total Claims
$256.3M
Total Cost
122,722
Prescribers
$20
Cost per Claim
3,761,958
Beneficiaries
30,631,695
30-Day Fills
$2,088
Avg Cost/Provider
105
Avg Claims/Provider
About Metoprolol Succinate
Metoprolol Succinate (sold as Metoprolol Succinate) was prescribed 12,847,535 times by 122,722 Medicare Part D providers in 2023, costing the program $256.3M. At $20 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 72 | Risankizumab-Rzaa (Skyrizi Pen) | $259.7M | 12,539 |
| 73 | Venetoclax (Venclexta) | $259.6M | 28,191 |
| 74 | Zanubrutinib (Brukinsa) | $256.8M | 19,239 |
| 75 | Metoprolol Succinate (Metoprolol Succinate) | $256.3M | 12,847,535 |
| 76 | Dolutegravir Sodium (Tivicay) | $251.7M | 102,995 |
| 77 | Abemaciclib (Verzenio) | $242.2M | 16,125 |
| 78 | Abacavir/Dolutegravir/Lamivudi (Triumeq) | $238.1M | 61,147 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology